URSA-PHARM-103: Statin PDC
- 27 Apr 2023
- 1 Minute to read
- Print
- DarkLight
URSA-PHARM-103: Statin PDC
- Updated on 27 Apr 2023
- 1 Minute to read
- Print
- DarkLight
Article summary
Did you find this summary helpful?
Thank you for your feedback
Measure Description
Among patients with a continuous period of plan membership of 180 days or longer in the 12 months prior to a snapshot date, and with 2 or more statin fills during that membership period, the percentage of days between the first qualifying fill and the earlier of the snapshot date or membership period end date with positive supply of statins.
Metadata
- Measure Type: Rate Measure
- Temporal Structure: Entity
- Component Class: Long-Form
- Denominator Case Field: Patient ID
- Target Direction: Up
Denominator Description
One per qualifying patient-episode.
Numerator Description
The statin PDC for the period from the first qualifying fill to the snapshot date or the end of the continuous membership period, whichever comes first.
Related Key Concepts
None.
FAQs
None.
Was this article helpful?